Quest Partners LLC Vera Therapeutics, Inc. Transaction History
Quest Partners LLC
- $575 Billion
- Q1 2024
A detailed history of Quest Partners LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 2,055 shares of VERA stock, worth $72,068. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,055
Previous 1,333
54.16%
Holding current value
$72,068
Previous $20.5 Million
332.21%
% of portfolio
0.02%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
174Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$185 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$116 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.17MShares$111 Million11.79% of portfolio
-
Abingworth LLP London, X02.96MShares$104 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$98 Million7.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $948M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...